arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

PRECISION OPTICS CORPORATION, INC.

POCI
$4.22 ▼ -0.02 (-0.47%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
64 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
26
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

PRECISION OPTICS CORPORATION, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $32.9M
Dividend Yield
Revenue Growth 108.0%
Op. Margin -0.7%
ROIC -0.3%
FCF / Share $-0.09
Trailing P/E
Price / Book 2.3x
FCF Yield
Debt / Equity 0.07
info Valuation on last close. End-of-day price, Aug 7, 2026.

64-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$8.71M
↑ +108.0%
Net Income Profit after all expenses
$-1.64M
↓ -24.8%
Operating Margin Operating profit as % of sales
-0.7%
↑ +96.9% 8th
FCF / Share Free cash flow per share
$-0.09
↓ -179.6%
Long-Term Debt Long-term obligations
$1.48M
↓ -9.1%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
8
Returns
17
Financial Health
49
Cash Quality
46

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 64 quarters